Ligand validation:2J19

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 2J19 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2J19_MAN_A_1309	94%	62%	0.077	0.977	0.5	0.93	-	1	0	0	100%	0.9167
2J19_MAN_A_1308	86%	56%	0.097	0.965	0.65	1.04	-	1	0	0	100%	0.9167
2J19_MAN_A_1307	80%	62%	0.092	0.941	0.54	0.9	-	1	0	0	100%	0.9167
2J19_MAN_A_1314	33%	60%	0.159	0.835	0.59	0.9	-	1	0	0	100%	0.9167
2J19_MAN_A_1313	14%	58%	0.192	0.739	0.53	1.06	-	1	0	0	100%	0.9167
2J19_MAN_A_1311	9%	59%	0.299	0.787	0.64	0.9	-	1	0	0	100%	0.9167
2J19_MAN_A_1317	8%	58%	0.234	0.697	0.65	0.92	-	1	0	0	100%	0.9167
2J19_MAN_A_1312	6%	55%	0.211	0.648	0.58	1.15	-	1	0	0	100%	0.9167
2J19_MAN_A_1310	6%	58%	0.292	0.72	0.61	0.96	-	1	0	0	100%	0.9167
7RST_MAN_A_304	97%	61%	0.06	0.978	0.65	0.82	-	-	0	0	100%	0.9167
2CIZ_MAN_A_1308	97%	66%	0.052	0.969	0.63	0.65	-	-	0	0	100%	0.9167
2CIY_MAN_A_739	97%	53%	0.056	0.969	0.74	1.09	-	1	0	0	100%	0.9167
2J18_MAN_A_1309	97%	61%	0.065	0.977	0.64	0.81	-	1	0	0	100%	0.9167
2CIV_MAN_A_1308	95%	62%	0.077	0.983	0.57	0.86	-	-	0	0	100%	0.9167
1GAI_MAN_A_480	100%	74%	0.043	0.986	0.45	0.53	-	-	0	0	100%	0.9167
5M03_MAN_A_402	99%	59%	0.034	0.989	0.56	0.99	-	-	0	0	92%	0.9167
1GAH_MAN_A_479	99%	76%	0.05	0.989	0.44	0.5	-	-	0	0	100%	0.9167
1BXO_MAN_A_328	99%	39%	0.05	0.985	1.37	1.08	1	1	0	0	100%	0.9167
7LTB_MAN_B_101	99%	58%	0.053	0.985	0.73	0.85	-	1	0	0	100%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.